NPPA and cardiac hypertrophy: Administration of rutaecarpine at 20 or 40 mg/kg/d could significantly improve cardiac hypertrophy in AAC-induced rats, which decreased (LV + S)/BW, (LV + S)/RV, and ANF mRNA expression in a dose-dependent manner and ameliorated the pathological changes of the left ventricle (Figure 1).